Recordati Take-Private, Amplifon Funding, Midea Esaote Deal

In a significant move within the European pharmaceutical sector, CVC Capital Partners has launched a €10.7 billion take-private offer for Italian drugmaker Recordati. This valuation, equating to €51.29 per share before dividends, positions the deal as one of the largest private equity-backed transactions in the region this year. The offer is spearheaded by CVC's partnership with Belgian investment firm Groupe Bruxelles Lambert (GBL), signaling strong conviction in Recordati's long-term growth prospects. The transaction is anticipated to finalize in the fourth quarter of 2026, subject to regulatory approvals.

The financing for this substantial acquisition is bolstered by a robust co-investment syndicate. Joining CVC and GBL are prominent institutional investors including the Abu Dhabi Investment Authority (ADIA), CPP Investment Board Private Holdings, PSP Europe, StepStone, AlpInvest, MGG Strategic SICAF SIF, and CapSol. This broad base of co-investors underscores the perceived value and stability of Recordati within the healthcare industry, a sector that continues to attract significant capital due to its defensive qualities and innovation potential.

Meanwhile, in the hearing aid market, Amplifon has successfully raised €453 million through an accelerated bookbuilding process. The issuance of new shares at €10 each will primarily fund the acquisition of the hearing unit of Denmark's GN Store Nord A/S (GN). This strategic move is valued at €2.6 billion on a debt-free enterprise basis. Key financial backing for Amplifon's expansion came from its existing shareholder Ampliter, contributing €100 million, and Tamburi Investment Partners (TIP), which injected €30 million. The acquisition will also be supported by a share swap and additional banking facilities, demonstrating a multi-pronged financing strategy.

In the medical technology space, Chinese conglomerate Midea Group is seeking full control of Italian firm Esaote. Midea, which currently holds a stake in Esaote, plans to acquire the remaining shares from entities such as Jiangsu Yuyue Technology Development, Shanghai Sharewin Equity Investment Fund Management, and Yunfeng Capital. Esaote, a specialist in diagnostic imaging and medical devices, was previously acquired by these investors in 2018 from a consortium including Ares Life Sciences, NB Renaissance, Equinox, and MP Venture. The proposed transaction awaits clearance from Italian antitrust authorities.

Further consolidating the European logistics sector, Bracchi, now under the ownership of Argos Wityu since 2023, has acquired German competitor Rostock Trans. This strategic integration aims to expand Bracchi's operational footprint and service capabilities across the continent. The deal structure includes a reinvestment by Rostock Trans' CEO, Lars Hennek, who will continue in a leadership role, ensuring continuity and leveraging his expertise. This move aligns with the broader trend of consolidation within the logistics industry, driven by the need for scale and efficiency in a competitive global market.

In the fashion retail arena, Marquee Brands, a portfolio company of Neuberger Berman, has agreed to acquire a majority stake in Italian luxury fashion house Roberto Cavalli. The seller is Dubai-based conglomerate DAMAC, which originally purchased the brand in 2019. The transaction, expected to close in the second quarter of 2026, sees DAMAC retaining a significant interest and continuing its focus on the brand's real estate and hospitality ventures. The Level Group (TLG) will serve as the strategic operating partner for Roberto Cavalli's fashion operations, aiming to revitalize and grow the brand's global presence.